India's Pharmaceutical Exports

Country Profile

Paraguay

Paraguay is an emerging destination for Indian pharmaceutical exports — $29.0M in FY 2025–26, with 3.9× growth over the past decade. Medicine Ingredients accounts for 50% of shipments, with vaccines contributing $2.16M. The compound annual growth rate since FY2015 stands at 13.2%.

🇵🇾 $29.0M · 3.9× growth since FY2015 · 13.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$29.0M
Exports FY2025–26 DGCIS
3.9×
Growth FY2015→2026
13.2%
CAGR FY2015→2026
50%
Medicine Ingredients Share
5
Product Categories Supplied
Paraguay is an emerging destination for Indian pharmaceutical exports — $29.0M in FY 2025–26, with 3.9× growth over the past decade. Medicine Ingredients accounts for 50% of shipments, with vaccines contributing $2.16M. The compound annual growth rate since FY2015 stands at 13.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $14.6M (50.3%) Medicines $11.3M (39.0%) Vaccines $2.16M (7.5%) Surgical & Hospital Supplies $876K (3.0%) Traditional & Herbal $54K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Paraguay in the RBI overseas direct investment dataset (2011–2026).